Literature DB >> 7666395

DNA microsatellite analysis of families with autosomal dominant polycystic kidney disease types 1 and 2: evaluation of clinical heterogeneity between both forms of the disease.

E Coto1, S Sanz de Castro, S Aguado, J Alvarez, M Arias, M J Menéndez, C López-Larrea.   

Abstract

We studied 17 large families affected by adult dominant polycystic kidney disease (ADPKD). Ultrasonographic analysis was performed on all the family members. DNA microsatellite markers closely linked to PKD1 on 16p13.3 were analysed, and linkage of the disease to this locus was determined. Families showing a negative linkage value were evaluated for linkage to the PKD2 locus on 4q. Five of the 17 families showed negative linkage for the 16p13.3 markers. In these families significant linkage to 4q was obtained. Renal cysts developed at an earlier age in PKD1 mutation carriers, and end stage renal failure occurred at an older age in people affected with PKD2. Analysis of large families with ADPKD in a Spanish population indicates that this is a genetically heterogeneous disorder, but mutations at only two loci are responsible for the development of the disease in most if not all the families. Clinicopathological differences between both forms of the disease occur, with subjects with ADPKD2 having a better prognosis than those with mutations at PKD1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666395      PMCID: PMC1050483          DOI: 10.1136/jmg.32.6.442

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

1.  Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1).

Authors:  M H Breuning; F G Snijdewint; H Brunner; A Verwest; J W Ijdo; J J Saris; J G Dauwerse; L Blonden; T Keith; D F Callen
Journal:  J Med Genet       Date:  1990-10       Impact factor: 6.318

2.  Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker.

Authors:  P C Harris; S Thomas; P J Ratcliffe; M H Breuning; E Coto; C Lopez-Larrea
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  Evidence of linkage disequilibrium in the Spanish polycystic kidney disease I population.

Authors:  B Peral; C J Ward; J L San Millán; S Thomas; R L Stallings; F Moreno; P C Harris
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

4.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

5.  The diagnosis and prognosis of autosomal dominant polycystic kidney disease.

Authors:  P S Parfrey; J C Bear; J Morgan; B C Cramer; P J McManamon; M H Gault; D N Churchill; M Singh; R Hewitt; S Somlo
Journal:  N Engl J Med       Date:  1990-10-18       Impact factor: 91.245

6.  Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16.

Authors:  S T Reeders; M H Breuning; G Corney; S J Jeremiah; P Meera Khan; K E Davies; D A Hopkinson; P L Pearson; D J Weatherall
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-29

7.  Linkage heterogeneity of autosomal dominant polycystic kidney disease.

Authors:  W J Kimberling; P R Fain; J B Kenyon; D Goldgar; E Sujansky; P A Gabow
Journal:  N Engl J Med       Date:  1988-10-06       Impact factor: 91.245

8.  Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers.

Authors:  M H Breuning; S T Reeders; H Brunner; J W Ijdo; J J Saris; A Verwest; G J van Ommen; P L Pearson
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

9.  A second genetic locus for autosomal dominant polycystic kidney disease.

Authors:  G Romeo; M Devoto; G Costa; L Roncuzzi; L Catizone; P Zucchelli; G G Germino; T Keith; D J Weatherall; S T Reeders
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

10.  A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16.

Authors:  S T Reeders; M H Breuning; K E Davies; R D Nicholls; A P Jarman; D R Higgs; P L Pearson; D J Weatherall
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

View more
  7 in total

1.  A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes.

Authors:  M Ariza; V Alvarez; R Marín; S Aguado; C López-Larrea; J Alvarez; M J Menéndez; E Coto
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

2.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Authors:  B Veldhuisen; J J Saris; S de Haij; T Hayashi; D M Reynolds; T Mochizuki; R Elles; R Fossdal; N Bogdanova; M A van Dijk; E Coto; D Ravine; S Nørby; C Verellen-Dumoulin; M H Breuning; S Somlo; D J Peters
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Autosomal dominant polycystic liver disease in a family without polycystic kidney disease associated with a novel missense protein kinase C substrate 80K-H mutation.

Authors:  Ramón Peces; Joost P H Drenth; Rene H M Te Morsche; Pedro González; Carlos Peces
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 4.  A mechanistic approach to inherited polycystic kidney disease.

Authors:  John J Bissler; Bradley P Dixon
Journal:  Pediatr Nephrol       Date:  2005-02-18       Impact factor: 3.714

5.  Haemochromatosis: a gene at last?

Authors:  K J Robson; J D Shearman; A T Merryweather-Clarke; J J Pointon; W M Rosenberg; A P Walker; J S Dooley; A Bomford; R Raha-Chowdhury; M Worwood
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 6.  Determinants of renal disease variability in ADPKD.

Authors:  Peter C Harris; Sandro Rossetti
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

7.  Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.

Authors:  Ramón Peces; Rocío Mena; Yolanda Martín; Concepción Hernández; Carlos Peces; Dolores Tellería; Emilio Cuesta; Rafael Selgas; Pablo Lapunzina; Julián Nevado
Journal:  Mol Genet Genomic Med       Date:  2020-06-13       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.